Scleroderma Renal Crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc), traditionally associated with anti-RNA polymerase III antibodies, corticosteroid use, and diffuse skin involvement. However, the role of COVID-19 as a potential trigger for SRC remains poorly understood. This study explores the occurrence of COVID-19-associated SRC, focusing on its clinical presentation, underlying risk factors, and outcomes
COVID-19, initially seen as a respiratory infection with mortality linked to respiratory failure, is now recognized as a multisystem disease, with acute kidney injury (AKI) evolving into chronic kidney disease (CKD); this study investigates AKI types and their prognostic value in hospitalized COVID-19 patients.